SCHEMBL13466373

SCHEMBL13466373

COC1CN(C(=O)c2ccc(C(C)C)cn2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G1B P04054 1/20 0.47
▸ ATG4B Q9Y4P1 1/20 0.47
▸ CCNC P24863 2/20 0.42
▸ CDK8 P49336 2/20 0.42
▸ SCN9A Q15858 3/20 0.41
▸ CDK19 Q9BWU1 1/20 0.41
▸ ACACB O00763 1/20 0.41
▸ GABRA1 P14867 1/20 0.40
▸ ADORA2A P29274 4/20 0.38
▸ SCN10A Q9Y5Y9 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ RIPK1 Q13546 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ GFER P55789 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13466383 0.85 PLA2G1B (0.43) PLA2G1BATG4BSCN9AACACBSCN10A
SCHEMBL13466364 0.85 PLA2G1B (0.45) PLA2G1BATG4BSCN9AACACBGABRA1
SCHEMBL16131136 0.84 PLA2G1B (0.36) PLA2G1BATG4BCCNCCDK8SCN9A
SCHEMBL16131994 0.82 PDE10A (0.53) CCNCCDK8SCN9ACDK19GABRA1
SCHEMBL13467180 0.81 CCNC (0.50) CCNCCDK8SCN9ACDK19GABRA1
SCHEMBL12186155 0.79 KMT2A (0.54) PLA2G1BATG4BTDP1NPC1LMNA
SCHEMBL10329767 0.79 SMN1; SMN2 (0.58) PLA2G1BATG4BTDP1DRD3NPC1
SCHEMBL20085608 0.79 KMT2A (0.58) LMNAMAPTSMN1; SMN2
SCHEMBL26772953 0.77 HRH3 (0.53) PLA2G1BATG4BTDP1NPC1LMNA
SCHEMBL24370438 0.76 TDP1 (0.48) PLA2G1BATG4BTDP1DRD3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012142329-A1 COMPOSITIONS AND THERAPEUTIC USES OF IKK-RELATED KINASE EPSILON AND TANKBINDING KINASE 1 INHIBITORS MYREXIS, INC. (US) 2012-10-18 — — WO disclosed
Send feedback